Results 201 to 210 of about 42,650 (280)

SCD1 Regulates Osteoclast Differentiation by Modulating Arachidonic Acid Metabolism and Mitochondrial Homeostasis

open access: yesThe FASEB Journal, Volume 40, Issue 10, 31 May 2026.
This graphical abstract illustrates that SCD1 inhibition by A939572 or the targeted nanovesicle POCM‐NP@A939572 reprograms arachidonic acid metabolism via the COX1‐HPGDS‐PGD2 axis and impairs mitochondrial homeostasis, thereby suppressing osteoclastogenesis and alleviating bone loss in osteoporosis.
Yihao Zhao   +12 more
wiley   +1 more source

Effect of combined anteversion on outcomes in total hip replacement. [PDF]

open access: yesBioinformation
Bansal S   +5 more
europepmc   +1 more source

Differential complement activation by alloantibodies in sickle cell hyperhaemolysis syndrome may influence disease course

open access: yes
British Journal of Haematology, Volume 208, Issue 6, Page 2311-2314, June 2026.
Mamie M. Thant   +4 more
wiley   +1 more source

Osteonecrosis in sickle cell disease: Contemporary orthopaedic practice and outcomes across African healthcare settings. [PDF]

open access: yesSICOT J
Oladeji EO   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy